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Sllmmary 
Previous studies have reported an association  of "//6 T  cells with microbial infection in both 
human lesions and murine infectious disease models. In this study we provide a comprehensive 
analysis of the conditions under which the induction of'y/6 T cells occurs at a site of infection. 
We found a site-specific induction of 3'/6 T  cells after  the injection of Listeria monocytogenes 
in the peritoneal cavity of C3H mice. No changes were seen in the splenic or lymph node populations 
after  these injections. Both the proportion and the absolute number of y/6 T  cells increased 
in the peritoneal cavity. Additionally, when peritoneal T cells from Listeria-immune mice were 
restimulated in vitro, the induced 'y/6 T cells exhibited a greater expansion potential than the 
cx//3 T  cells. Neither the induced '),/6 T  cells nor those from normal mice expressed CD4 or 
CD8 on the cell surface. Thy-1 was expressed on only 29% of normal peritoneal "y/6 T cells, 
but after intraperitoneal Listeria injection 65% of induced y/6 T  cells expressed Thy-1. Pgp-1 
and CD45R expression on both normal and induced ~//6 T cells was consistent with an activation 
phenotype. Significant increases in peritoneal 3'/6 T cells were not seen until 5-7 d after Listeria 
injection. The proportion of the CD3 + population expressing the "y/6 T cell receptor remained 
elevated for 6-7 wk, while the absolute numbers of peritoneal "y/6 T  cells declined gradually 
over this time period, reflecting a decrease in both the number oflymphocytes and the percentage 
of these that were CD3 + . Peak numbers of',//6 T cells were seen at day 10 with live microbes 
such as Listeria.  A variety of microbes, toxins, mitogens, antigens, cytokines, and nonspecific 
inflammatory agents were evaluated for their ability to induce 3,/6 T cells in the peritoneal cavity. 
Both Gram-positive and Gram-negative bacteria as well as Mycobacteria were able to induce y/6 
T cells that showed increased in vitro expansion potential. An exotoxin from a Gram-positive 
organism, listeriolysin-o, and the lipopolysaccharide (LPS) endotoxin from a Gram-negative organism 
were also effective. "y/6 T cell responses to LPS were under Ips gene control. Peak numbers of 
3'/6 T cells were observed at day 3 after injection with exotoxins and endotoxins. Modifications 
that abrogated the virulence of a bacterial  strain also eliminated the inductive effect for y/6 T 
cells. Although injection of some nonspecific peritoneal inflammatory agents resulted in increased 
numbers of'y/6 T cells in the peritoneum, these cells did not have increased expansion potential 
in vitro. Depletion of either or//3 or 3'/6 T  cells in vivo with monoclonal antibody resulted 
in mice with impaired resistance to primary infection with Listeria. However, the memory response 
in immunized mice was virtually unaffected by depletion of ~//6 T cells, supporting the hypothesis 
that this T cell subset is of greatest importance in innate "front-line" defense mechanisms. Thus, 
the highly localized and inducible expression of 3'/6 T cells in the murine peritoneal cavity not 
only supplies evidence for the role of 3~/6 T  cells in microbial immunity but also provides an 
excellent opportunity for elucidating the function, receptor specificity, and activation requirements 
of 3~/6 T  cells. 
A 
alient feature of the immune system is the remarkable 
heterogeneity of T lymphocytes and the functional diver- 
sity represented by the collection of specialized cellular subsets. 
A newly recognized subdivision of T  cells is based on the 
A portion of this work was presented in abstract form (Skeen, M. J., and 
H. K. Ziegler. 1992. Induction of peritoneal "y/6 T cells by microbial toxins. 
]. Cell. Biochem. Suppl. 16D:71). 
differential  expression of TCKs. The antigen-specific  TCK 
is composed of an o~ chain paired with a/3 chain or a 3' chain 
associated with a 6 chain. Very early in T cell development, 
cells become committed to express either c~ and/3 chain gene 
products or y and 6 proteins. As such, distinct T cell lineages 
are generated that express either the o~//3 TCR or the "y/6 
TCR. 
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tinctive localization in epithelial tissue (1-4)  and at sites of 
infection (5-7). This association at sites of first contact with 
infectious agents implicates  3'/~ T  cells in "front-line" de- 
fense reactions or regulatory mechanisms important at the 
self-nonself interface.  The preferential expression  of 3'/# T 
cells can theoretically be due to the selective homing and/or 
proliferation of cells controlled by a number of factors unique 
to 3'//~ T  cells and a particular site or inflammatory condi- 
tion such as microbial infection. Such controlling factors in- 
dude homing receptors, antigens or superantigens, presenting 
molecules, accessory molecules, and cytokines. A clearer pic- 
ture of the function of 3r//~ T  cells will be achieved with a 
more through understanding of the regulation of their tissue 
expression. 
While generalizations about the antigens recognized by 
'y/~ T cells are difficult to make with certainty, recognition 
of carbohydrate antigens (8, 9), viral proteins (10), and epi- 
topes of stress proteins shared by microbes and mammals (11, 
12) has been observed.  The observations on recognition of 
stress proteins have led to interesting speculations about a 
primitive surveillance system in which 'y/~ T cells discriminate 
stressed  from nonstressed cells. 
The predominance of 3,/(3 T  cells has been noted at sites 
of infection with Mycobacteria  (5, 13), Listeria  (7), influenza 
virus (14), Trypanosoma  cruzi (15), and leishmania (16). In 
the present study we have analyzed the induction of "y/~ T 
cells in the peritoneal cavity of mice injected with microbes 
and their toxins. These studies provide a comprehensive analysis 
of the conditions under which the induction of'y/~ T cells 
occurs at a site of infection and suggest that the peritoneal 
cavity is a tissue site for preferential expression and induction 
of34~ T cells. Additionally, by using antibody depletion tech- 
niques in vivo, we provide evidence that the site-specific in- 
duction of "y/~ T cells after infection may play a significant 
role in primary resistance to murine listeriosis.  In contrast, 
c~/3  T  cells were found to be responsible for the specific 
memory response. 
Materials and Methods 
Mice and Injections.  Female  C3HeB/FeJ or C3H/HeJ mice ob- 
tained from The Jackson Laboratory (Bar Harbor, ME) were used 
at 8-12 wk of age. Mice were housed in micro-isolator cages with 
laboratory chow and water available ad libitum. Injections were 
performed aseptically  intraperitoneally unless otherwise indicated. 
Bacterial Strains.  The following strains of bacteria were used 
at concentrations  as indicated  in the text: Listeria monocytogenes strain 
43251 (wild type; American Type Culture  Collection [ATCC], 
Rockville, MD) (LDs0 =  5  x  104); L. monocytogenes strain 43250 
(ATCC) (a  spontaneous mutant lacking the expression of the 
hemolysin molecule (LDs0 >8  x  10  s) (18); hemolysin-expressing 
Escherichia cot WAF270 (strain J198 transformed with pSF 4000, 
a plasmid  that encodes  hemolysin);  hemolysin-negative  E. coli WAF 
280 (strain  J198 transformed with the transposon mutant pSF4000; 
Tnl in which the transposon is inserted in the hemolysin gene); 
bacille Calmette-Guerin (BCG; Dr. Bruce Zwilling, Ohio State 
University, Columbus, OH); and Salmonella typhiraurium strain 
SL1004 (obtained from Dr. John Spitznagel, Emory University, 
Atlanta, GA). The transformed E. coli strains were kindly provided 
by Dr. Rodney Welch (University of Wisconsin, Madison, WI). 
Before injection, frozen stocks of  bacterial strains were grown over- 
night in brain heart infusion broth (Difco Laboratories, Detroit, 
MI) at 370C with aeration. Cells were washed three times in PBS, 
and  concentrations  were determined by optical density  with 
confirmation by colony counts on brain heart infusion agar plates. 
For heat-killed preparations, bacteria were incubated at 80~  for 
1 h and tested for lack of viability on agar plates. 
Reagents.  PHA, Con A, sodium m-periodate, OVA grade VI, 
and poly(I:C) were obtained from Sigma Chemical Co. (St. Louis, 
MO). Recombinant mouse IFN--y  was purchased from Amgen Inc. 
(Thousand Oaks, CA). Proteose peptone was from Difco Labora- 
tories and S. minnesota K595 LPS was from Ribi ImmunoChem 
Research Inc. (Hamilton, MT). SRBC were from Carr-Scarborough 
Inc. (Decatur, GA) and were washed three times with PBS before 
use. Listeriolysin-O (LLO)  1 preparations were generated in our 
laboratory as previously described (17, 18). Briefly,  crude prepara- 
tions were precipitated with saturated ammonium sulfate  from su- 
pernatants from 18-24-h L. monocytogenes cultures, then dialyzed 
exhaustively  before use. Recombination LLO was derived as previ- 
ously described from lysates ofE. coli BB4 containing the plasmid 
pT10E into which the structural gene for LLO had been inserted 
(19). Briefly,  bacteria were lysed by freezing and thawing and the 
lysates were sonicated to reduce viscosity before sterile filtration. 
Bacteria containing the unaltered plasmid served as a control. LLO 
peptide 215-234, which has been shown to be a dominant epitope 
for T cells in C3HeB/FeJ mice (18), was synthesized using an au- 
tomated peptide synthesizer  (430A; Applied Biosystems,  Inc., Foster 
City, CA) in the Microchemistry Department at Emory Univer- 
sity. The peptide was purified  by HPLC and its structure confirmed 
by microsequencing. 
Cell Harvesting and In  Vitro Culture.  Peritoneal  exudate cells 
(PEC) were obtained by peritoneal lavage with HBSS containing 
0.06% BSA, 10 mM Hepes buffer, 50 U/ml penicillin, 50 #g/ml 
streptomycin, and 10 U/ml heparin. Macrophages were depleted 
by incubation in tissue  culture dishes for 1 h at 37~  Plastic  nonad- 
herent cells were passed over nylon wool columns using standard 
procedures (20) to further enrich for T cell populations. A portion 
of these cells was analyzed  by flow cytometry. The remainder were 
incubated at 37~  in 24-well plates at 106 cells/well in combina- 
tion with 2.5  x  106 irradiated (3,000 tad) splenic accessory  cells 
in a total volume of 2 ml. Culture media was KPMI 1640 sup- 
plemented with 10% FCS, 5  x  10 -s M 2-ME, 0.5 mM sodium 
pyruvate, 10 mM Hepes buffer, 50 U/ml penicillin, 50 #g/ml strep- 
tomycin, and 2 mM r-ghtamine. Either Con A (2 #g/ml) or heat- 
killed preparations of the immunizing bacteria were added as indi- 
cated in the text. Surviving cells were harvested  on Ficoll-Hypaque 
gradients (Lymphocyte Separation Medium;  Organon  Teknika 
Corp., Durham,  NC) after 4 d and analyzed by flow cytometry. 
The ratio of the number of cells of a TCK phenotype in this sur- 
viving population to the number of cells of that phenotype in the 
initial population was operationally defined  as the expansion factor 
for that subset. When the proportion of cells of a given subset 
(e.g., "y/~  T cells) increases after culture, this reflects  both the en- 
hanced proliferation  and survival of that subset relative to the other 
subset (e.g., ~//~ T cells). This measurement is described in more 
detail in the companion paper (21). 
Single-cell suspensions  were made from excised  spleens or lymph 
nodes using a glass homogenizer and RBC were lysed from the 
1 Abbreviations used in this paper: LLO, listeriolysin-o;  PEC, peritoneal 
exudate cells. 
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were analyzed by flow cytometry or cultured in vitro as described 
above. 
Antibodies.  Specificities and sources are as follows: anti-CD3, 
hybridoma 145-2Cll (22) provided by Dr. Jeffrey Bluestone (Univer- 
sity of Chicago, Chicago, IL) or purchased as a PE conjugate (Phar- 
Mingen,  San Diego,  CA); anti-~/~  TCK, hybridoma  H57-597 
(23) provided by Dr. Ralph Kubo (National Jewish Hospital, Denver, 
CO); antiw//$ TCR, hybridoma UC7-13D5 provided by Dr. Jeffrey 
Bluestone or hybridoma GL3 (24) provided by Dr. Leo LeFrancois 
(University of Connecticut, Farmington, CT); anti-V3'2, hybridoma 
UC3-10A6 from Dr. Jeffrey Bluestone; anti-V3'/3, hybridoma F536 
(25) provided by Dr.  James  Allison  (University  of California, 
Berkeley, CA); anti-V/s4, hybridoma GL2 (24) provided by Dr. Leo 
LeFrancois; anti-CD4,  hybridoma GK1.5 (26) (ATCC TIB 207); 
anti-CD8,  hybridoma 53-6.72 (27) (ATCC TIB 105); anti-Pgp-1, 
hybridoma IM-7 (28) (PharMingen); anti-CD45K, hybridoma 23G2 
(29) (PharMingen); anti-IL-2R FITC, hybridoma 7D4 (30) (Phar- 
Mingen);  anti-Thy-l-PE,  hybridoma  53-2.1 (27) (PharMingen); 
anti-mouse IgG-FITC (Southern Biotechnology, Birmingham, AL); 
and anti-rat IgG-PE (Southern Biotechnology).  mAbs generated 
from cell lines in the laboratory were purified from culture super- 
natants by protein A affinity chromatography  (20) or from serum- 
free culture supernatants by saturated ammonium  sulfate precipi- 
tation. Purified antibodies were directly conjugated to FITC using 
standard techniques (20). The 3,//$ TCK expression was confirmed 
using both available antibodies (UC7-13D5 and GL3) directly con- 
jugated to FITC.  Both antibodies gave identical results. 
Flow Cytometry.  Cells (1-5  x  l0  s) were incubated on ice for 
30 min with 25 #1 of a predetermined  optimal concentration  of 
mAb, washed twice with PBS containing  3% FCS and 0.1%  so- 
dium azide, and fixed with 1% paraformaldehyde in PBS. If pri- 
mary antibodies were not directly conjugated  to either FITC or 
PE, the incubation with primary antibody was followed by a second 
incubation for 30 min on ice with an appropriate second antibody 
conjugated to a fluorochrome. Binding ofisotype-matched control 
Ig was used to determine background levds of immunofluorescence. 
For two-color analyses involving the use of a secondary antibody, 
the incubations,  which involved three different antibodies, were 
carried out in a sequence that had been previously determined  to 
minimize  background  staining. Samples were  analyzed  (5,000 
cells/sample) on a FACScan  |  (Becton Dickinson & Co., Mountain 
View, CA) using forward scatter/side scatter gating  to select the 
lymphocyte population for analysis. For evaluation of surface marker 
expression on T cell subsets using two-color analysis, a second gate 
was used to select the appropriate subset and 5,000 of those cells 
were evaluated. In some experiments, cells were analyzed after ad- 
herence to plastic without further purification on nylon wool. These 
cells are termed peritoneal plastic nonadherent  (PNA).  To mini- 
mize nonspecific immunofluorescence in these samples, cells were 
preincubated with an anti-Fc receptor mAb (FcBlock; Pharmingen) 
before addition  of specific antibodies. 
In  Vivo Depletion of T  Cell Subsets.  Mice were injected  in- 
traperitoneally with 200 #g of purified anti-TCK e~/B (H57-597) 
or anti-TCR 3,//$ (GL3) or with hamster IgG (Accurate Chemical 
Co., Westbury, NY) as a species and isotype-specific  control. Deple- 
tion of T cell subsets was monitored  by flow cytometry in both 
the peritoneal and splenic populations. The course of a Listeria in- 
fection was monitored in these mice by enumerating bacterial colo- 
nies grown from serial 10-fold dilutions of homogenized livers and 
spleens. Cells were lysed with 1% Triton X-100 to release intracel- 
lular bacteria before incubation  for 48 h at 37~  on brain heart 
infusion  agar plates. 
Results 
Intraperitoneal Injection of L. monocytogenes Results in a Site- 
specific Increase in 7/8 T Cells, Which Then Expand to a Greater 
Degree than Do cr/13 T Cells When Restimulated In Vitra  On 
day 10 after intraperitoneal  injection of 6  x  103 viable L. 
monocytogenes (LDs0  =  5  x  104), the proportion of y//$ T 
cells in the CD3 + population  in the peritoneal cavity was 
increased more than threefold as compared with PBS-injected 
mice (Fig.  1 A, top two rows). The proportion of CD3 + ceils 
in PEC was also increased in L/ster~-infected mice (Fig.  1 
A).  The combined effect of these two changes resulted in 
an "~10-fold increase in the actual number of 7//$ T  cells in 
the  peritoneal  cell population  (see  Table  1).  If the  nylon 
wool-nonadherent PEC were then cultured in vitro for 4 d 
with irradiated splenic accessory cells and L/ster/a antigen prepa- 
rations, the resulting population was 97% CD3 + , of which 
44% were 7//$ T cells (Fig.  1, A). In multiple experiments 
the percentage of "),//$ T  ceils in the population  generated 
in vitro in response to Listeria  antigens ranged from 36 to 
59%.  Heat-killed  Listeria  (107/ml)  and  crude  LLO  (10 
#g/m1) were routinely used in combination to stimulate the 
T ceils in vitro, although either antigen preparation used alone 
gave similar results (data not  shown).  LLO is an exotoxin 
that has been shown to be a dominant  antigen for ol//3 T 
cells  in L/ster/a-infected mice (18). 
This preferential expansion of'),//$ T cells in vitro was even 
greater if Con A rather than specific antigen was used as a 
stimulant in vitro. The percentage of 3'//$ T cells in the Con 
A-stimulated population averaged 65%0 (n  =  7) and ranged 
from 42 to 87%  (see Fig.  1 B, top row, for example).  This 
preferential expansion was not seen in PBS-injected mice, in 
which the proportion of'),//$ T cells did not change signifi- 
candy after Con A stimulation in vitro (see Table 1). An ex- 
pansion factor for T cell subsets was calculated based on the 
ratio of the number of cells of a TCR phenotype in the ini- 
tial population as compared with the number of cells of that 
phenotype in the population harvested after 4 d of Con A 
stimulation. Both selective proliferation and ceil survival likely 
contribute to the operationally defined expansion factor.  The 
expansion factor for 3'//$ T  ceils from Listeria-infected mice 
in response to Con A in vitro averaged 3.2 (SD  =  2.2) while 
the ~/B  T  cell expansion factor averaged 0.8 (SD  =  0.7) 
in four experiments.  Similar differences were seen if Listeria 
antigens were used to stimulate the T ceils in vitro (2.8-fold 
expansion (SD  =  0.9) for 3'//$ T  ceils compared with  1.5- 
fold expansion  (SD  =  0.3) for ol//3 T  cells). 
This induction/activation phenomenon for 3#/$ T ceils was 
site specific  in that  no increases  in the percentages  of 3///$ 
T  cells  in  splenic or lymph  node populations  of Listeria- 
immune mice were observed. Mesenteric as weU as axillary 
and inguinal lymph nodes were examined and found to be 
unaffected (data not  shown).  The "),//$ T  cells represented 
<5% of the fleshly isolated spleen or lymph node cells and 
did not show preferential expansion in vitro in response to 
Con A,  remaining  at  ~,2%  of the CD3 + cells (Fig.  1 B). 
Kinetics of')'/8 T Cell Induction in the Peritoneal Cavity.  A 
series of experiments was conducted in which PEC were ex- 
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Figure  1.  CD3/TCK  pheno- 
type of various cell populations ana- 
lyzed by flow cytometry. Horizontal 
axes represent log fluorescence in- 
tensity and vertical axes represent 
frequency  of events. Incubation with 
the appropriate  purified  primary  mAb 
was followed with anti-mouse IgG 
FITC. Nonspeeific fluorescence is 
shown as the unshaded area in each 
panel and the number in the boxes 
on the right represents the percent- 
ages of "y/~ T cells in the CD3 + 
population. (.4) 7/~ T cells were 
significantly increased in peritoneal 
cell populations freshly  isolated  from 
mice immunized  with virulent  L/s- 
ter/a (6  x  103 i.p.) 10 d before har- 
vest (middle),  as compared to PBS- 
injected  mice  (top).  Cells  from 
Listeria-immunized  mice that were 
cultured for 4 d in vitro in the pres- 
ence of 107/ml heat-killed Listeria 
and 10/~g/ml LLO (bottom) showed 
an increased frequency of "y/~ T 
cells. (B) Cells from three anatom- 
ical sites in L/ster/a-immunized  mice 
were  expanded  in  vitro  with  2 
/~g/ml Con A and then examined 
for CD3/TCR expression by flow 
cytometry. Preferential  expression  of 
~/6 T cells was specific  to the peri- 
toneal cavity. Resuks are represen- 
tative of several experiments. 
amined at intervals after intraperitoneal Listeria injection to 
examine the kinetics of the inductive response. A representa- 
tive experiment is shown in Fig. 2 A. (Note also the kinetics 
shown in control animals in Figs. 4 and 5.) Increased percen- 
tages of3'/6 T cells were first seen 5-7 d after injection. The 
proportion of 3"/6 T cells continued to increase, reached a 
plateau between days 10 and 20, and remained elevated for 
6-7 wk (data not shown).  The number of peritoneal 3'/6 
T  cells per mouse was calculated based on the number of 
PEC harvested and the percentages of CD3 + and 3,/6 + T 
cells as determined by flow cytometry. This value peaked on 
day 10 and then declined sharply, reflecting decreases  in both 
the peritoneal  lymphocytosis  and the percentage of CD3 + 
cells in the PEC.  The numbers continued to decline more 
gradually and eventually returned nearly to baseline by 8-9 
wk postinjection even though the percentage of 3'/6 T cells 
remained slightly elevated (data not shown). Thus, increased 
numbers of 3"/6 T cells are noted at times of active infection 
(days 4-6) and the peak accumulation of 3,/6 T cells is noted 
m2-3 d after infection has resolved. These results differ from 
those in a previous report (7), in which an increase in perito- 
neal y/6 T cells was seen 2-3 d after Listeria  injection fol- 
lowed by a rapid decline and a return to normal levels by 
day 10. These data were obtained, however, by Northern blot 
analyses of mRNA, which may at least partially explain the 
differences. 
Preliminary experiments had indicated that intraperitoneal 
injection of LPS also induced peritoneal 3'/6 T cells. The ki- 
netics  of this  response  to  a  microbial  endotoxin differed 
significantly from the response to a viable microbe in that 
the percentage of 3'/6 T cells peaked on day 3 and then began 
a gradual decline (Fig. 2 B). The number of peritoneal 3'/6 
T cells decreased even more rapidly, returning to near base- 
line levels by day 10. These differences in kinetics may reflect 
the time necessary for the live microbe to generate factors 
that affect the composition of the T  cell population. 
Su~face Marker Expression on Peritoneal y/~  T  Cells.  Al- 
though most subpopulations of  3,/6 T cells from various tissue 
sites  express  neither  CD4  nor  CD8  on  their  surface,  a 
significant proportion of the 3'/6 T cells in the intraepithelial 
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Figure 2.  Kinetics of3'/~5  T cell induction in the peritoneal cavity. Nylon 
wool-nonadherent  cells  (NWNA)  from PEC  from mice injected  in- 
traperitoneally  with 6  x  103 Listeria/mouse  (A) or 1/zg of R595 LPS 
(B) were examined, at the indicated intervals after injection, for CD3/TCR 
expression by flow cytometry as described for Fig. 1. R~sults were confirmed 
in a second experiment.  Results  are expressed as the percentage  of "y/~ 
T cells in the CD3 + population  and as the number of 3'/~ T cells/mouse. 
The latter value was calculated based on the number of peritoneal  cells 
harvested per mouse and the percentage of those cells that expressed CD3 
and  the 3'/(5 TCR. 
lymphocyte population from the intestinal lining express CD8 
(31, 32). Neither resident nor L/ster/a-induced peritoneal 3'//~ 
T cells exhibited detectable surface expression of CD4 or CD8, 
while peritoneal ct/fl T cells expressed these markers as an- 
ticipated (Fig.  3 and Table 1). Thy-1 has also been reported 
to be variably expressed on qr/~5 T cell populations. Only 29% 
(SD  -- 9, n  =  7) of the resident peritoneal 3'/(5 T cells were 
Thy-1 +. After infection with Listeria,  65% (SD  --  7, n  = 
9) of peritoneal 3'/~ T cells were Thy-1 + . Injection of LPS 
did not result in an increase in Thy-1 expression. The in- 
crease in Thy-1 + cells in L/ster/a-injected  mice continued for 
at least 3 wk but had returned to baseline by 7 wk after in- 
jection. Thy-1 has been reported to be an inducible marker 
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Figure  3.  Peritoneal 3~/~f T cells from L/ster~-immunized  mice do not 
express CD4 or CDS, but approximately  two-thirds are Thy-1 +. In con- 
trast,  or//3 T cells are >95%  Thy-1 + and CD4/CD8 + . Two-color flow 
cytometry was used to analyze surface marker  expression on peritoneal 
NWNA cells. Cells were first incubated  with either anti-CD4 and anti- 
CD8 or with anti-Thy-1 mAb followed by anti-rat IgG-PE and finally with 
FITC-conjugated  anti-TCR mAb. Horizontal axes represent green and ver- 
tical axes represent red fluorescence intensity. Boundaries for positive and 
negative populations were established based on binding ofisotype-matched 
Ig controls.  Numbers in each panel represent the percentages of the total 
population within that quadrant. 
on intestinal epithelial 3'/~ T  cells, perhaps in response to 
microbial stimulation (33).  Thy-1 was expressed on >95% 
of peritoneal or/3 T cells in all treatment groups as expected. 
We also compared the expression on peritoneal 3'//~ and 
odfl T cells of the activation markers Pgp-1 and CD45R (Table 
1). Cells were evaluated using two-color immunofluorescence 
on day 10 after injection of PBS or Listeria and on day 3 after 
injection of LPS.  In both ot/fl and 3,/c5 T  cells isolated in 
four separate experiments from Listeria-infected  mice, a high 
frequency of cells expressed Pgp-1 (98% SD  =  1% of 3,/it 
T cells and 93% SD  =  5% ofot/fl T cells), consistent with 
an  activation  phenotype.  Interestingly,  both  subsets  also 
showed high frequencies of Pgp-1 expression on resident peri- 
toneal cells (94%  SD  =  3%  for ~'/d T  cells and 71%  SD 
=  19% for ot/fl T cells), confirming the generally accepted 
concept that  the peritoneal cavity is  a repository of acti- 
vated/memory cells. The CD45 molecule is expressed on the 
cell surface as a series of isotypes that are generated by exon 
splicing.  We used the 23G2 mAb, which is B exon depen- 
dent (34). Previous studies have shown that the isotypes that 
include the B exon are expressed on nonactivated cells (34-36); 
thus, a CD45R lo phenotype is associated with activated cells. 
This marker was the most variably expressed of those that 
we investigated on peritoneal T cells. In some experiments, 
injection of Listeria seemed to cause a shift toward a reduced 
975  Skeen and Ziegler Table  1.  Phenotype of y/6  T  cells 
Peritoneal ~//5 T  cells 
Fresh  Con A stimulated 
Marker  PBS  LM  LPS  PBS  LM  LPS  PBS 
Peritoneal a//3 T  ceils 
Fresh  Con A stimulated  LN 
,x//~ 
LM  LPS  PBS  LM  LPS  T ceils 
% of CD3§  cells 
CD4/CD8  <2  <2  <2  <2  <2  <2  >98  >98  >98  >98  >98  >98  >98 
Thy-1  29  65  30  31  71  41  >95  >95  >95  87  97  84  95 
Pgp-1 (CD44)  94  98  97  96  99  99  71  93  90  96  98  92  <10 
CD45K lo  68  79  76  35  69  75  54  63  66  49  38  30  <10 
The phenotype of T cells was determined  by two parameter FACS  |  analysis as described in Fig. 3 and Materials and Methods. Values represent 
the mean percentage of CD3 + cells expressing the indicated surface marker or phenotype. Cell populations were from mice injected intraperitone- 
ally with the indicated material (PBS, live L. monocytogenes [LM] or LPS). Cells were analyzed  on the day of harvest (Fresh) or after 4-d culture 
with Con A (Con A-stimulated) as described in Materials and Methods. The right-hand  column  represents the analysis  of ot/B cells from the lymph 
nodes (LN) of normal mice. 
expression of CD45K. However, when results from five ex- 
periments were averaged, no significant differences in CD45K 
expression on 3"/6 T cells were seen between PBS and Listeria- 
injected mice (68% CD45tL 1o in PBS controls as compared 
with 79% in Listeria-immune  mice, with SD of 20%  and 
19%, respectively).  Similarly, no significant differences be- 
tween control and immunized mice were seen with respect 
to CD45K expression on or//3 T cells, although the frequency 
of CD45K lo cells was lower than in the 3//6 T cell popula- 
tion (54%  in PBS controls and 63% in immunized mice.) 
Injection of LPS did not alter the frequencies  of peritoneal 
T cells expressing either Pgp-1 or CD45K. For comparison, 
lymph node ot/B T cell populations from PBS- and Listeria- 
injected mice were examined and found to be <10% Pgp-1 + 
and <10%  CD45K lo, 
Expression of Thy-1, Pgp-1,  and CD45K was also evalu- 
ated in populations that were expanded in vitro with Con 
A, but no significant changes were found compared to the 
starting populations (Table 1). This is in contrast to the IL- 
21L, which is  undetectable on freshly isolated PEC  from 
Listeria-infected mice but is expressed on both cr  and 3//6 
T  cells after 4 d of culture with Con A  (data not shown). 
These results were obtained using the 7D4 mAb antibody 
to the IL-2tL and are consistent with previous studies in which 
this antibody bound at detectable levels to T cells only after 
in vitro stimulation with Con A (30). Thus, the significant 
changes were found in surface marker expression  on perito- 
neal 3//6 T cells were the increase in Thy-1 expression in vivo 
after Listeria injection and the induction of the IL-2K during 
in vitro restimulation. 
We also evaluated the expression  of particular V  region 
gene products (V3/2, V3/3, and V64) for which mAbs were 
available. Unlike the preferential V region expression reported 
in various other tissue sites (37),  the 3"/6 T cells present in 
the peritoneal cavity show no detectable expression  of these 
V  gene segments. This was evidenced by the finding that 
the appropriate mAbs stained <1% of peritoneal 3"/6 T cells 
induced by either Listeria or LPS (data not shown). The "nega- 
tive" results  with antibodies to  V3/2, V3/3, and V64  are 
significant, we believe,  since we have confirmed that these 
antibodies do stain the appropriate  subsets in the spleen, skin, 
and intestinal epithelium, respectively. The peritoneal T cells 
may express either an as yet undefined V segment preference 
or may be a diverse polyclonal population of T  cells. 
Induction of'r/6 T  Cells in the Peritoneal Cavity Is Caused 
by a Variety of  Microbes and Their Toxins.  Since increased per- 
centages of 3//6 T cells could be reproducibly induced in the 
peritoneal cavity by intraperitoneal injection of either a viable 
Gram-positive microbe (Listeria) or an endotoxin (LPS) from 
a Gram-negative microbe, we sought to evaluate thoroughly 
the conditions under which this induction occurred. This 
series of experiments is summarized in Table 2. Results are 
expressed both as the number of peritoneal 7/6 T cells per 
mouse and as the percentage of 3'/6 T  cells in the CD3 § 
population of either freshly isolated cells or of cells stimu- 
lated for 4 d in vitro with Con A. In all experiments, the 
percentage of ot/B T  cells was also measured to be certain 
that the sum of these two subsets was equal to the CD3 § 
population.  As a further confirmation, the percentages  of 
CD4 +  and  CD8 +  cells  were  also  determined  (data  not 
shown). The sum of these two populations was always equiva- 
lent to the ot/fl T cell percentage. Cells were also restimu- 
lated in vitro with antigen preparations from the immunizing 
bacterial strain where appropriate (data not shown). Results 
from antigen restimulation mirrored those with Con A re- 
stimulation, except that differences between the T cell subsets 
were not as great. Each condition was examined at least twice 
and numbers are mean values of replicate  experiments. 
Dramatic induction of 3//6 T cells was noted with the in- 
jection of live virulent strains of Listeria.  The initial studies 
were carried out using a  wild-type, virulent,  hemolysin- 
producing strain of L. monocytogenes. The hemolysin mole- 
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Injection 
Fresh  T  cells  Con A blasts 
"yI8 + cells  "y/~+ cells 
No. of  as percent of  as percent of 
3,/8 + cells  total  total 
per mouse  T  cells  T  cells 
10 d before harvest 
3 d before harvest 
x  1,000 
PBS i.p.  14  12  8 
Hly + L.M.i.p.  (6  x  103)  136  2_11  65 
Hly-  L.M.i.p.  (6  x  103)  3  7  5 
Heat-killed L.M.i.p.  (10  s)  14  14  11 
Hly § L.M./peptone i.p.  (6  x  103)  27_22  26  70 
2nd Hly § L.M./i.p. (6  x  10  4)  147  28  4_55 
Hly § L.M.s.c.  (6  x  103)  10  23  11 
Peptone i.p.  (1.5  ml of 10%)  41  14  7 
LLO 215-234 s.c.  in CFA (50/ig)  17  17  11 
OVA s.c.  in CFA (50 #~g)  2  4  7 
SRBCs i.p.  (103)  7  7  4 
Con A  (100 #g) i.p.  80  12  9 
BCG i.p.  (106)  190  9  2_0 
Hly § E.C.i.p.  (l&)  16_66  40  3__22 
Hly-  E.C.i.p.  (I(Y)  72  39  13 
S.T.i.p.  (10  6)  5_33  2_66  20 
S.T.i.p.  (10  s)  65  2_9_0  48 
LPS (1 #g) in C3Heb/FeJ Mice i.p.  19___00  31  55 
PBS i.p.  14  12  8 
Hly + L.M.i.p.  (6  x  103)  17  9  5 
LPS (1 #~g) in C3Heb/FeJ mice i.p.  54  31  2_77 
LPS (1 /lg) in C3H/HeJ mice i.p.  12  8  NT 
rLLO (400 U) i.p.  398  34  199 
Peptone (1.5  ml of 10%)  i.p.  13  14  10 
Con A (100/zg)  i.p.  25  13  14 
PHA (35  #g) i.p.  25  18  12 
rlFN-'),  (5,000  U  b.i.d.) i.p.  9  7  13 
NalO4  (1 mg) i.p.  160  25  16 
Thioglycollate i.p.  (2.5  ml of 3%)  10___11  43  17 
Poly (I:C) (100/~g) i.p.  10  17  20 
Cells expressing CD3, et/fl TCR, or 3:/~ TCR were quantitated using flow cytometry. Underlined values represent those showing consistent in- 
creases greater than twofold above PBS control. Injections were in C3HeB/FeJ mice unless otherwise noted. L.M., L. monocytogenes; E.C., E. coli; 
S.T., S. typhlmurium. 
cule, LLO, has been shown to be both a major virulence factor 
(38) and a major antigenic component (18) of Listeria. Strains 
of Listeria  that do not express LLO (lily- strains) are poorly 
immunogenic and have LDs0's that are 4-5 logs greater than 
Hly +  strains.  Heat-killed Listeria  are likewise very poorly 
immunogenic. Neither Hly- nor heat-killed Listeria induced 
peritoneal "y//t T cells after intraperitoneal injection (Table 2). 
Injection site-specific induction was indicated by the finding 
that although viable Hly + Listeria  are both virulent and im- 
munogenic when injected intraperitoneaUy or subcutaneously, 
977  Skeen and Ziegler only the intraperitoneal  route of administration  resulted in 
an induction of qr/8 T cells in the peritoneal cavity. In other 
studies in our laboratory (Pearce et al., manuscript in prepa- 
ration), we have noted that intragastric inoculation of Listeria 
produced changes in the 3r/8 T cell vs. o~//~ T cell composi- 
tion in the intestinal epithelial lymphocytes (IELs) and demon- 
strable systemic infection in the spleen and liver. However, 
intragastric inoculation did not cause changes in the perito- 
neal 3'/8 T cells and, conversely, intraperitoneal inoculation 
caused no changes in T cell subset composition in the IELs 
(data not shown). Additionally, subcutaneous  injection in CFA 
(containing a nonviable form of Mycobacterium boris) of the 
protein antigen OVA or of an immunodominant peptide epi- 
tope of LLO (LLO 215-234) (18) did not induce peritoneal 
"y/8 T cells. Even highly immunogenic particulate antigens 
such as SRBC failed to significantly induce peritoneal 3'/8 
T cells. Considered collectively, these data suggest that the 
induction of 3//8 T cells is a site-specific reaction  to infec- 
tion, rather than a systemic response to microbial injection 
or antigenic  challenge. 
We also wanted to determine whether this response was 
generalizable to a variety of bacterial strains. The results (Table 
2) indicate that when injected intraperitoneally,  Gram-negative 
bacteria such as E. coli (E.C.) and S. typhimurium  (S.T.) and 
a strain ofMycobacteria (BCG) can also induce peritoneal y/8 
T cells. As with Listeria,  the in vitro expansion potential of 
peritoneal T  cells was enhanced by injection of Salmonella 
and was influenced by the number of bacteria injected. The 
percentage of 3'/8 T cells in freshly isolated PEC did not in- 
crease after BCG injection, but the absolute number per mouse 
was elevated and a modest level of preferential increase in ex- 
pansion was observed. These results were somewhat surprising 
since several reports have implicated a role for y/8  T  cells 
in the response to Mycobacteria (5, 6, 9,  13). Since BCG is 
relatively avirulent,  it is possible that fully virulent strains 
of Mycobacteria may produce a more dramatic induction of 
"y/8 T  cells. This idea is being tested. Overall,  our survey 
indicates that virulent Listeria were especially effective in the 
induction of 3'/8 T  cells. 
Since the production of the hemolysin LLO appeared to 
be essential for y/8 T  cell induction by Listeria,  the effect 
of the ct hemolysin of E. coli was investigated using a pair 
of E. coli strains expressing a plasmid containing either an 
intact hemolysin gene (hlyA) or one in which the structural 
gene had been disrupted with a transposon.  The strain that 
expressed hemolysin (Hly  + E.C.) induced a greater number 
of'y/8 T cells per mouse than the hemolysin-negative strain 
(Hly-E.C.) (Table 2). There was also a greater increase in 
response to Con A restimulation of 3~/8 T cells from mice 
injected with Hly  + E.C. than from mice injected with Hly- 
E.C.  strain. 
Given the finding that both exotoxins and endotoxins ap- 
peared to play a critical role in the induction of'y/8 T cells, 
we evaluated further the activity of isolated toxins. The in- 
duction of"//8 T cells by LPS was observed in the LPS high 
responder mouse strain (C3HeB/FeJ)  but no induction oc- 
curred in the LPS low responder (C3H/HeJ). Thus, like many 
of the responses to LPS, the induction of 3~/8 T  cells ap- 
peared to be under strict control of the Ips gene, implying 
that lipid A is the biologically active portion of LPS in this 
system. We also noted that a recombinant preparation of the 
exotoxin LLO was a potent inducer of the number of perito- 
neal 3'/8 T  cells in C3H/HeJ mice. (Table 2). 
The significance of microbial stimulation was understood 
by the fact that strong induction of y/8 T cells was not ob- 
served  with  several common  peritoneal  inflammatory 
stimulants. We evaluated the effects of peptone alone or in 
combination with Listeria with respect to its effect on peri- 
toneal  3,/8  T  cells. Injection  of peptone  alone  did  not 
significantly affect the 3'/8 T cell population on day 3 and 
showed only a moderate increase in cell number on day 10 
after injection (Table 2). The only difference between mice 
injected with Listeria alone and those injected with Listeria 
plus peptone was an increase in the number of 7/6 T cells 
per mouse in the latter group (e.g., values of 136 vs.  272 
in Table 1). In our survey, we also investigated a variety of 
known peripheral inflammatory agents and agents that have 
been shown to alter the peritoneal cell populations. The PEC 
were harvested on day 3 after intraperitoneal  injection since 
the effects  of most inflammatory agents are known to be max- 
imal 3-5 d after injection.  Neither Con A, PHA, rlFN-% 
nor poly(I:C)  altered the 3'/6 T  cell population (Table 2). 
Under these conditions rlFN-'y caused a marked increase in 
class II  MHC  expression by peritoneal  macrophages  and 
poly(I:C) dramatically increased NK cell activity, as expected 
(data not shown). Injection of sodium m-periodate, a T cell 
mitogen, and thioglycollate, a peritoneal inflammatory agent, 
resulted in increased  percentages and absolute numbers of ~//8 
T  cells, but in neither case did these cells expand in vitro 
in response to Con A to the extent exhibited by the 7/6 T 
cells induced in response to microbial injection.  Since Con 
A was such a potent in vitro stimulator of "//6 T cells acti- 
vated in vivo by microbial infection, the effect of Con A in 
vivo 10 d after injection was also evaluated. The number of 
"y/8 T cells was increased, but the percentage was unchanged 
and these cells did not significantly expand during in vitro 
restimulation.  Thus, induction of y/8 T cells did not neces- 
sarily accompany other known induction events in the peri- 
toneal cavity, and our results taken together represent strong 
evidence that bacterial infection is intimately and uniquely 
associated with profound regulation of 3'/8 T  cells. 
Depletion of Either cr/~ or y/~ T Cells In Vitro Impairs Re- 
sistance to Infection with Listeria.  T cell subsets were depleted 
by intraperitoneal injection of anti-TCR mAb before the in- 
jection of Listeria  2 d later. Both the phenotype of T  cell 
subsets and extent of bacterial infection were monitored on 
days 2, 5, and 8 after injection of Listeria.  The extent of T 
cell subset depletion  in both the peritoneal  cavity and the 
spleen is shown in Figs. 4 and 5. The relative proportions 
of the two subsets are shown in Fig. 4, while the absolute 
numbers of these cells are depicted in Fig. 5. Injection of anti- 
TCK mAb results in subset-specific  depletion, which remained 
effective throughout the course of the experiment. In fact, 
depletion persisted for at least 30 d with no additional anti- 
body injections (data not shown). Note that in the control 
group, injected with hamster IgG, the general increase in T 
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Figure 4.  Percentages  of c~/~ and 7/~ T cells in the CD3 + popula- 
tions from spleen or peritoneal cavity of T cell-depleted mice. Mice were 
injected intraperitoneally  with 200/~g of either control IgG (hamster), 
anti-TCR s/E, or anti-TCR 3'//i. 2 d later, 6  x  103 Listeria were injected 
intraperitoneally.  Animals were kiUed on days 2, 5, and 8 after Listeria 
injection and examined for T cell phenotype and level of bacterial infec- 
tion (Fig. 6). Spleen cells and peritoneal plastic nonadherent cells (PNA) 
were pooled from four mice and examined by flow cytometry to deter- 
mine TCR phenotype. 
cell numbers associated with a Listeria infection occurred in 
both the spleen and peritoneal cavity, as anticipated. In the 
groups treated with anti-TCR antibody, however, these in- 
creases were detectable only in the untreated subset. Also note 
that the number of ~'/~ T  cells in the peritoneal cavity in 
the group depleted of o~//J T cells is less than in the control 
group (Fig.  5, lower right).  This may reflect the dependence 
of 3'//~ T cells on o~/~ T cells as observed in vitro and detailed 
in the companion paper (21). 
Although the depletions are not absolute, in that small 
numbers of cells in the depleted subsets are still detectable, 
this treatment has a profound effect on the resistance to a 
primary Listeria infection (Fig.  6).  By day 8, the infection 
was completely cleared in the control group but continued 
in mice depleted of either c~//3 or 3,//t T ceUs. Although the 
effect was somewhat heterogeneous on day 8 in the group 
depleted of 3'//J T cells, there is a dear indication that a se- 
vere reduction in the numbers of 3'//~ T cells allows for per- 
sistence and increased magnitude of a Listeria  infection. 
In contrast, the resistance to a challenge dose of Listeria 
in mice that had been primed with an immunizing dose of 
Listeria was virtually unaffected by in vivo depletion of 3'/5 
T ceils. On day 4 after the challenge injection, bacterial clear- 
ance was comparable in primed mice that were either injected 
with control IgG or that were depleted of 3'/~ T cells (Table 
3). Depletion of ol/~ T cells, however, resuhed in dramati- 
cally higher bacterial numbers after challenge (Table 3). These 
same trends were apparent very early after the second Listeria 
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Figure 5.  Absolute numbers of 
T cell subsets in the spleen and peri- 
toneal  cavity  of  T  cell-depleted 
mice. Mice were treated as described 
in Fig. 4. The numbers of T cells 
of each subset in a tissue site were 
determined based on the total cell 
yield from that site, the percentage 
of those cells expressing CD3, and 
the proportion of e~/3 or ~//6 T 
cells in the CD3 + population. Bacteria per Spleen  (X I0000) 
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Figure  6.  Infection  with L/ster/a 
in T cell-depleted mice. Depletion 
of r  and 3'/~ T cells in vivo alters 
infection with Listeria. Mice were 
treated as described in Fig. 4. Or- 
gans from individual animals were 
evaluated for the number of bacterial 
colonies that developed when cell 
lysates  were  incubated  on  agar 
plates. Each bar represents an in- 
dividual  mouse  and  results are 
pooled from two separate experi- 
ments.  Minimal  detection  limits 
under conditions of the experiment 
were 100 colonies per organ; max- 
imum  quantifiable colonies were 
10  s. Numbers in each panel repre- 
sent arithmetic means. Data were 
analyzed by a sign rank test using 
nonparametric analysis; differences 
between the control group  (IgG) 
and the antibody-treated groups at 
each day were compared. In the 
spleen at day 2, the differences  were 
not significant (p =  0.56 for anti- 
y/fi Ab and 0.11 for anti-odB Ab). 
At day 5 in the spleen, significant 
differences were judged for both antibody-treated groups (p  =  0.0156). At day 8 in the spleen,/,  values were 0.063 for anti-'y/~ Ab and 0.0156 for 
anti-cx/B Ab. In the liver at day 2, p  =  0.656 for anti-v/fi Ab and 0.0156 for anti-~x/B Ab. In the liver at day 5,/,  =  0.0156 for anti-3,/~ Ab and 
0.0156 for anti-odor Ab. In the liver at day 8, p  =  0.0625 for anti-'y/fi Ab and 0.0156 for anti-odB Ab. The marginally significant differences with 
anti-'y/~ Ab at day 8 were due mainly to the fact that there were two ties at the minimal detection limits (0.01  x  104 bacteria per organ). That 
is, two animals appeared to clear the infection in the anti-v/~ Ab-treated  groups. 
injection (days 1 and 2; Fig.  7), confirming the importance 
of odB  T  cells in  the  memory response. 
Discussion 
The findings of this study provide direct experimental evi- 
dence of the tissue site-specific association of3'/~ T  cells with 
bacterial infection.  Previous reports have linked y//~ T  cells 
to sites of microbial infection in both human lesions  (5,  6, 
38) and murine infectious disease models (7, 13). Our results 
show that the accumulation of'y/6 T  cells at the site of in- 
fection is dependent  upon the presence of either a virulent 
form of bacteria or its exotoxin or endotoxin.  Heat-killed 
or other avirulent forms of bacteria are relatively ineffective, 
suggesting  that an active production  of virulence factors is 
necessary for the  induction  of "y/~ T  cells. 
The mechanism of "y/6 T  cell induction  in vivo may be 
conceptualized  in  two fundamental  ways.  The presence  of 
y/~ T  cells could be due either to a recruitment of cells into 
the inflammatory site or to enhanced proliferation. A selected 
proliferation may be due to a T  cell repertoire unique to "y/6 
T  cells. Microbial antigens, such as heat shock proteins (HSPs) 
and HSPs expressed by the host, may be upregulated by the 
toxins expressed by pathogenic bacteria. Furthermore, induc- 
tion may be favored by presenting molecules, accessory mol- 
ecules,  and cytokines that  are both influenced by infection 
and specifically required for "y/~ T cell proliferation. An evalu- 
ation of these hypotheses represents a central focus for our 
ongoing  research. 
The "y/fi T  cells that accumulate in the peritoneum after 
microbial injection appear to be activated both with respect 
to the cell surface expression of proteins that have been shown 
to be associated with activated or memory T  cells and with 
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Figure  7.  No evidence for involvement of'y/5 T cells in the memory 
response. Shown is immunity to secondary challenge with Listeria. Listeria- 
primed mice were depleted of a/fl or 7/~ T cells, then challenged with 
Listeria as described in Table 3. Age-matched control groups were either 
unprimed and not depleted of T cells or were primed but not depleted. 
T cell depletions were confirmed by flow cytometry. Each bar represents 
results from an individual mouse. Results are from spleen colonies; similar 
trends were apparent in livers and PEC. 
980  Peritoneal  3'/6 T  Cells and Bacterial Infection Table  3.  Depletion of ot/~ and T/8  T  Cells In  Vivo: Role of cr/~  T  Cells in Secondary Challenge with  Listeria 
Bacteria per organ  (mean) 
Mouse 
Treatment  number  Liver  Spleen 
Primed/control  IgG 
Primed/anti--y/~  TCK IgG 
Primed/anti-c~/fl  TCK IgG 
Unprimed/control  IgG 
￿  Io, ooo 
1  0.19  0.03 
2  2.82  0.75 
3  4.52  (4.8)  1.10  (3.2) 
4  15.60  13.60 
5  1.05  0.48 
1  0.19  0.05 
2  1.61  0.25 
3  1.73  (4.3)  8.30  (2.5) 
4  11.20  0.50 
5  6.80  3.40 
1  16,650.00  6,000.00 
2  559.00  2,420.00 
3  4,980.00  (6,312)  9,700.00  (5,226) 
4  7,020.00  5,460.00 
5  2,355.00  2,550.00 
1  35,800.00  18,200.00 
2  24,000.00  10,700.00 
3  42,300.00  (32,388)  19,000.00  (16,240) 
4  10,790.00  15,400.00 
5  49,050.00  17,900.00 
Primed mice were infected with a sublethal dose of Listeria (9  x  103/mouse) 4 wk before antibody treatment. Unprimed mice were uninfected 
age-matched controls. Mice were treated with purified IgG (200 gg/mouse i.p.) of either control normal hamster IgG (control  IgG), H57 mAb (anti- 
ot/fl TCR IgG), or GL3 mAb (anti-7/8 TCR IgG). 3 d later mice were challenged with 106 viable Listeria intraperitoneally. 4 d after challenge, 
Listeria colony counts were determined from plated lysates of liver and spleen. Depletion of the appropriate subset of T cell was confirmed by flow 
cytometry as illustrated in Figs. 4 and 5. 
respect to their ability to expand rapidly when restimulated 
in vitro. The reduced expression of CD45R or the expres- 
sion of high levels of Pgp-1 are not apparently sufficient for 
an increased in vitro expansion potential, however, since peri- 
toneal 3,/8 T  cells from mice injected with PBS express an 
activation phenotype but do not significantly expand when 
restimulated in vitro with Con A. We have noted that  in- 
creased Thy-1 positivity of the induced 3'//~ T cells correlates 
to some degree with a preferential  expansion potential in vitro, 
but the generality of this observation and mechanistic basis 
for this finding remains for further  study.  Clearly, the ex- 
pansion potential in vitro is related to the nature of the in 
vivo induction process, during which some other portions 
of the cellular activation  pathway are apparently initiated. 
This induction phenomenon seems to be related to microbes 
and their toxins since injection of nonspecific peritoneal inflam- 
matory agents does not increase the in vitro expansion potential 
of 3'/~ T cells even though injection of some of these agents 
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is accompanied by increases in the numbers of peritoneal 3'/8 
T cells. This activation state of microbial-induced peritoneal 
qr/8 T cells may alter the ability of these cells to release var- 
ious cytokines or to respond to cytokine signals from other 
cells in the network of the immunoregulatory pathway. The 
characteristics of selective 3~//~ expansion in vitro to IL-1 and 
IL-7, as described in our companion paper (21), lend biolog- 
ical feasibility to a mechanism favoring selective expression 
of cytokines. IL-1 production is certainly a common feature 
shared by successful 'y/~ T cell-inducing agents. Perhaps IL-7 
is also selectively expressed in the tissue sites and under con- 
ditions produced by bacterial infection. 
The increases  in 3'/8 T  cells in the peritoneal cavity after 
injection of live virulent microbes did not occur until 5-7 d 
after  the  initial  injection  and  persisted  for  several  weeks. 
Carding et al. (14) have reported a similar delayed appearance 
and a persistence of 3'/~ T  cells  in inflammatory  exudates 
from lungs of mice inected with influenza.  This is in con- trast to previous reports of an early appearance (day 3) of 
3`/8 T  cells in the peritoneal cavity of mice injected with 
Listeria  (7) followed by a relatively rapid decline by day 13 
postinfection (39).  These investigators also report a depen- 
dence on the injection ofproteose peptone in order to generate 
large increases in 3,/8 T cells after Listeria infection (39). Our 
results do not support these findings. The differences between 
the findings are difficult to reconcile since similar mouse strains 
were used (C3HeB/FeJ or C3H/HeN). The analytical meth- 
ods differed, however, in that in the current study 3`/8 T 
cells were quantitated by immunofluorescence using a mAb 
specific  for the 3,/8  TCR  (UC7-13D5  or GL3),  whereas 
in the other studies the 3'/8 T cells were quantitated either 
by  analysis  of  mRNA  production  or  by  evaluation  of 
CD3 +  CD4- CD8-  populations  by  immunofluorescence. 
Synthesis of mRNA for 3"/8 TCR in the absence of cell sur- 
face expression of the receptor in cells isolated from lung 
inflammatory exudates has been reported (40,  41). 
Hiromatsu et al. (39) have reported that Listeria organisms 
were cleared less rapidly from the spleens of mice whose 3`/8 
T  cells had been reduced by in vivo injection of anti-TCR 
3`/8 mAb before injection ofListeria. Our results with deple- 
tion of 3`/8 T cells in vivo confirm and extend these observa- 
tions (Figs. 4-6). Our results differ from this previous report 
in that exacerbation of listeriosis  was most marked in our 
study at later times during infection. We also extend these 
findings by clearly documenting the antibody-mediated deple- 
tion of the relevant subsets.  Our results are also consistent 
with those of Dunn and North (42),  in which a Thy-l+, 
CD4-,  and CD8-  cell population was implicated in resis- 
tance to listeriosis.  The protective role of 3'/8 T  cells may 
be related to their ability to respond to activation signals that 
are induced by microbes or their toxins. Preliminary results 
have indicated that peritoneal 3'/6 T  cells elaborate IFN-3` 
in response to infected or activated macrophages in vitro (our 
unpublished observations).  The role of IFN-3` in limiting 
Listeria infection has been well documented (43, 44). IFN-3` 
could certainly play an important role in limiting infection 
through augmentation of microbicidal function of macro- 
phages as well as favoring the induction of macrophage MHC 
gene expression that would in turn augment antigen-specific 
T  cell responses (17). The observation that 3`/8 T  cells are 
not significantly involved in the anamnestic response supports 
the hypothesis that these cells are involved in "front-line" 
immune defense mechanisms. These findings are also com- 
patible with the view that the 3`/8 TCR is fixed during evo- 
lution to particular tissue sites rather than shaped by anti- 
genic challenge and clonal selection. The nature of the antigens 
recognized, the activation signals  operative, and the mech- 
anistic basis of the role of 3"/8 T cells in innate defense reac- 
tions remain to be elucidated. 
Finally, we wish to emphasize that the murine peritoneal 
cavity provides an ideal model for the study of 3"/8 T  cells. 
Even in the absence of immunization, the normal popula- 
tion of peritoneal cells is composed of '~10% 3"/8 T  cells, 
a significantly higher percentage than in spleen or lymph node 
populations. The fact that this peritoneal population can be 
altered under a variety of specific conditions, as reported here, 
provides a defined experimental system for investigating the 
relationship between 3'/8 T  cells and infectious disease.  In 
this system 3'/8 T cells are induced in sufficient numbers for 
further experimental analysis. The observation that the acti- 
vation state of the 3'/8 T cells is altered by microbial infec- 
tion offers a system in which the immunobiology of 3'/8 T 
cells is amenable to precise analysis. 
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